Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      GSK Consumer Healthcare appoints Rahul Kapoor as Executive Vice President-HR

      GSK Consumer Healthcare appoints Rahul Kapoor as Executive Vice President-HR

      Ruby Khatun Khatun24 April 2018 10:00 AM IST
      New Delhi: GSK Consumer Healthcare said it has appointed Rahul Kapoor as executive vice-president-HR for India sub-continent (ISC) region.Kapoor will...
      FDA panel against higher dose of Lilly-Incyte arthritis drug

      FDA panel against higher dose of Lilly-Incyte arthritis drug

      Ruby Khatun Khatun24 April 2018 9:45 AM IST
      An arthritis drug developed by Eli Lilly & Co and Incyte Corp should not be approved at a 4-milligram dose, advisers to the U.S. FDA voted, in a...
      FDA declines to approve Pfizer biosimilar of Roches cancer drug

      FDA declines to approve Pfizer biosimilar of Roche's cancer drug

      Ruby Khatun Khatun24 April 2018 9:30 AM IST
      Pfizer Inc said U.S. regulators declined to approve the company’s biosimilar of Roche’s blockbuster treatment for breast cancer, Herceptin and sought...
      Clouds over Indian hospital chain Fortis keep suitors from making higher bids

      Clouds over Indian hospital chain Fortis keep suitors from making higher bids

      Ruby Khatun Khatun24 April 2018 9:18 AM IST
      MUMBAI/BENGALURU: India’s Fortis Healthcare Ltd has received as many as five offers for control of its private hospital business, but suitors have so...
      Twitter co-founder invests in Delhi based online healthcare platform Visit

      Twitter co-founder invests in Delhi based online healthcare platform Visit

      Ruby Khatun Khatun23 April 2018 10:42 AM IST
      New Delhi: Twitter co-founder Biz Stone has invested in his "personal capacity" in a Delhi-based health startup that uses an artificial...
      PIL in HC against new tender to empanel chemists under CGHS

      PIL in HC against new tender to empanel chemists under CGHS

      Ruby Khatun Khatun23 April 2018 10:30 AM IST
      New Delhi: The Delhi High Court has sought the response of the Centre on a PIL challenging an e-tender issued for empanelment of authorised local...
      Novartis appoints John Tsai as Head of Global Drug Development and CMO

      Novartis appoints John Tsai as Head of Global Drug Development and CMO

      Ruby Khatun Khatun23 April 2018 10:15 AM IST
      Basel: Novartis announced the appointment of John Tsai, M.D. as Head of Global Drug Development (GDD) and Chief Medical Officer.Dr. Tsai will join...
      Merck seeks partners for cancer and immune system drugs

      Merck seeks partners for cancer and immune system drugs

      Ruby Khatun Khatun23 April 2018 10:00 AM IST
      FRANKFURT: Merck KGaA will seek development partners for experimental treatments including tepotinib as the German company looks to licensing deals to...
      Asembia expands collaboration with Pfizer oncology

      Asembia expands collaboration with Pfizer oncology

      Ruby Khatun Khatun23 April 2018 9:45 AM IST
      Asembia members can now gain expanded access to Pfizer Oncology defined distribution oncology products for qualified hospital and health system...
      Biogen boosts investment in neurology with 1 billion dollar Ionis deal

      Biogen boosts investment in neurology with 1 billion dollar Ionis deal

      Ruby Khatun Khatun23 April 2018 9:30 AM IST
      Biogen Inc struck a $1 billion neurology drug development deal with Ionis Pharmaceuticals, expanding a partnership that developed the company’s...
      HC Rescues Lupin on Price cap on powdered form of asthma drug

      HC Rescues Lupin on Price cap on powdered form of asthma drug

      Ruby Khatun Khatun22 April 2018 11:58 AM IST
      New Delhi: The Delhi High Court directed the Centre not to take any coercive measure against Indian pharma major Lupin Ltd which has challenged a...
      Glenmark Pharma gets USFDA nod for scalp and skin treatment drug

      Glenmark Pharma gets USFDA nod for scalp and skin treatment drug

      Ruby Khatun Khatun22 April 2018 10:30 AM IST
      New Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for a generic version of Temovate Topical Solution used...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok